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Abstract
Background. In a previous study we demonstrated that
mild metabolic alkalosis resulting from standard bicarbon-
ate haemodialysis induces hypotension. In this study, we
have further investigated the changes in systemic haemo-
dynamics induced by bicarbonate and calcium, using non-
invasive procedures.
Methods. In a randomized controlled trial with a single-
blind, crossover design, we sequentially changed the
dialysate bicarbonate and calcium concentrations (be-
tween 26 and 35mmol/l for bicarbonate and either 1.25
or 1.50mmol/l for calcium). Twenty-one patients were
enrolled for a total of 756 dialysis sessions. Systemic
haemodynamics was evaluated using pulse wave analysers.
Bioimpedance and BNP were used to compare the fluid
status pattern.
Results. The haemodynamic parameters and the pre-
dialysis BNP using either a high calcium or bicarbon-
ate concentration were as follows: systolic blood pressure
(+5.6 and −4.7mmHg; P < 0.05 for both), stroke volume
(+12.3 and +5.2ml; P < 0.05 and ns), peripheral resis-
tances (−190 and −171 dyne s cm−5; P < 0.05 for both),
central augmentation index (+1.1% and −2.9%; ns and
P < 0.05) and BNP (−5 and −170ng/l; ns and P < 0.05).
The need of staff intervention was similar in all modalities.
Conclusions. Both high bicarbonate and calcium concen-
trations in the dialysate improve the haemodynamic pat-
tern during dialysis. Bicarbonate reduces arterial stiffness
and ameliorates the heart tolerance for volume overload in
the interdialytic phase, whereas calcium directly increases
stroke volume. The slight hypotensive effect of alkalaemia
should motivate a probative reduction of bicarbonate con-
centration in dialysis fluid for haemodynamic reasons, only
in the event of failure of classical tools to prevent intradia-
lytic hypotension.
Correspondence and offprint requests to: Luca Gabutti, Division of
Nephrology, Ospedale la Carit` a, via Ospedale 1, 6600 Locarno,
Switzerland. Tel: +41918114693; Fax: +41918114533; E-mail:
luca.gabutti@eoc.ch
Keywords: alkalosis; bicarbonate; calcium;
haemodialysis; haemodynamics
Introduction
Despite the fact that the severity of chronic metabolic aci-
dosis secondary to end-stage renal failure in haemodialysis
patients can vary widely depending on dialysis frequency
and quality and on protein intake, the bicarbonate concen-
tration in the dialysis fluid is often set arbitrarily some-
where between 32 and 35mmol/l [1,2]. This strategy is the
result of a compromise between the advantages of correct-
ing pre-dialysis acidosis and the side effects of the transient
peri- and post-dialysis alkalosis resulting from bicarbonate
transfer. The undesirable consequences, on the one hand, of
metabolic acidosis on bone metabolism [3–5] and nitrogen
balance [6,7] and, on the other, of metabolic alkalosis on
neuromuscular excitability and on cerebral blood flow [8–
10] are well known. Furthermore, the positive inotropic ef-
fectinduced byalkalaemia inexperimental models[11,12],
if effective in humans, could be at least in part counterbal-
anced by the secondary decrease of serum ionized calcium
concentration[13].Infact,thedirectrelationship,mediated
by its inotropic effect (a concomitant increase in peripheral
resistance is controversial), between an acute rise or fall in
ionized calcium and blood pressure has been exhaustively
demonstrated in haemodialysis [14–20]. With reference to
the haemodynamic consequences of bicarbonate transfer, a
symptomatic intradialytic hypotensive effect of alkalaemia
has been observed in two previous studies, the first one
(n = 4) performed with 40 mmol/l and the second one
(n = 26) with 32mmol/l of bicarbonate in the dialysis fluid
[21,22]. As a consequence, even though the correction of
chronic metabolic acidosis is an important goal of dialy-
sis, it was suggested, in patients showing a significant peri-
and post-dialysis alkalaemia and in the event of failure of
the classical tools to prevent intradialytic hypotension, to
consider a reduction of the bicarbonate concentration in the
dialysis fluid [22].
C   The Author [2008].
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Fig. 1. Study design. Schematic representation of the study design.
However,inafurtherstudydesignedtoascertainwhether
the calcium shift secondary to alkalaemia explained the ob-
served haemodynamic consequences, the decrease in blood
pressurewasnotsignificant,probablyduetoaninsufficient
statistical power (243 versus 468 dialysis sessions) [19].
Moreover, the haemodynamic pattern of the postulated hy-
potensive effect was, in the above-cited studies, not investi-
gated in detail. For these reasons, we designed a new study
in which we (i) analysed non-invasively the haemodynamic
consequences of sequentially changing the dialysis fluid
bicarbonate and calcium concentrations and (ii) monitored
theoccurrence ofintradialytic hypotensive episodes aswell
as their impact on acid–base, electrolyte and fluid status.
Methods and patients
Twenty-one chronic haemodialysis patients (10 males and
11 females) were enrolled in the study. Each patient was
dialyzed for 4 hs three times a week, was clinically sta-
ble and had no intercurrent illnesses. Using a single-blind,
cross-over design, after a baseline observation phase of
6 weeks, the patients were randomized in the two arms
of the study, beginning by changing either the bicarbon-
ate or the calcium concentration in the dialysis fluid. This
first 3-week intervention phase was followed by a week
of wash out going back to the baseline dialysis prescrip-
tions and then, switching round the bicarbonate and cal-
cium prescriptions compared to the initial randomization,
by a second 3-week intervention phase (for a schematic
representation see Figure 1). The adaptation of the bicar-
bonate and calcium concentrations in the dialysis fluid in
the intervention phases was done as follows: in one arm,
patients with a baseline bicarbonate ≥30mmol/l were dia-
lyzedreducingtheconcentrationby6mmol/lwhilepatients
initially treated with a bicarbonate <30mmol/l were dia-
lyzed increasing the concentration by 6mmol/l; in the other
arm, the ionized calcium concentration was changed from
1.25 to 1.50mmol/l or vice versa. The haemodialyses were
performed using a 4008H machine, calibrated to deliver
a bicarbonate concentration of between 24 and 40mmol/l
from a sodium bicarbonate bag Bibag
C  , and a high flux
polysulfone membrane, all from Fresenius Medical Care
(Bad Homburg, Germany). The prescribed, dialyzer effec-
tive surface area, dialysis fluid conductibility, temperature
and composition and effective blood flow were recorded
at the moment of enrolment in the study. These potential
variables, with the exception of the dialysate bicarbonate
and calcium concentrations, were then left unchanged for
the following 13 weeks. The medications of the patients
(including phosphate binders) were also kept constant.
Serum BUN and creatinine were measured at the be-
ginning and at the end of the first dialysis session of the
third week of each study phase. Whole blood pH, ionized
calcium, sodium and potassium were measured at the be-
ginning of each dialysis session and at the end of the 3rd
dialysissessionsofeachweekusingapointofcareionome-
terbydirectionometry.Thebrainnatriureticpeptide(BNP)
concentrationwasdeterminedatthebeginningofeachdial-
ysis session. Blood samples were taken from the arterial
limb of the shunt.
The ionized sodium concentration of the dialysis fluid
produced by each dialysis machine was determined once
at the beginning of each treatment modality by indirect
ionometry.
Systolicanddiastolicbloodpressuresandheartratewere
measuredbeforestartingthesession,every30minthrough-
out the dialysis and 5 min after the end of the procedure
with an automated Blood Pressure Monitor 4008 (Frese-
nius Medical Care, Bad Homburg, Germany) integrated in
the dialysis machine. Stroke volumes (integrated mean of
the flow waveform between the current upstroke and the
dicrotic notch) and peripheral resistances (ratio of mean ar-
terial pressure to stroke volume multiplied by heart rate)
were evaluated before starting the session and then ev-
ery hour using a finger beat-to-beat monitor Finometer
C  
(FinapresMedicalSystemsBV,Arnhem,TheNetherlands).
As a quality control, a pulse wave analysis with calculation
of the central aortic indices (augmentation index, central
augmented pressure, central systolic and diastolic BP, end
systolic BP, ejection and diastolic duration) was performed
threetimesineachstudyphaseinthemiddle2hofthedial-
ysis session using a Sphigmocor
C   (Atcor Medical, West
Ryde, Australia). A body impedance analyser BIA 101
C  
and the software Bodygram 1.3 (both from Akern Biore-
search, Pontassieve, Italy) were used before starting each
dialysis session to estimate the total body, intracellular and
extracellularwater(TBW,ICWandECWrespectively).The
use of isotonic saline (100–200ml) infusions to treat symp-
tomatic hypotension or symptoms related to intravascular
hypovolaemia was registered.
Fig. 2. Analysis of the haemodynamic parameter fluctuations. Schematic
representation of the method used to calculate the maximum increase and
decrease of each measured parameter during the dialysis session.H
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Table 1. Characteristics of the studied population
Patient no. Sex (M/F) Age (years) Underlying nephropathy Comorbidities Medication Dry weight (kg) Dialyzer surface Kt/V
area (m2)
Ischaemic Diabetes Beta Calcium Alpha ACE-inhibitors
cardiomyopathy mellitus blockers antagonists blockers or ARB
1 F 74 Diabetic nephropathy Y Y Y N N Y 70.0 1.8 1.59
2 F 87 Nephroangiosclerosis N N Y Y N Y 63.0 1.8 1.38
3 M 71 Diabetic nephropathy Y Y N N N Y 85.0 1.8 1.28
4 F 84 Rapidly progressive
glomerulonephritis
Y N Y Y Y Y 57.5 1.8 1.88
5 M 79 Diabetic nephropathy Y Y N N N N 62.0 1.8 1.28
6 F 56 Focal segmental
glomerulosclerosis
N N Y Y N N 104.0 1.8 1.81
7 M 58 Focal segmental
glomerulosclerosis
N Y Y Y N N 80.0 2.2 1.46
8 F 79 Rapidly progressive
glomerulonephritis
Y N Y N N N 44.0 1.8 1.85
9 M 64 Focal segmental
glomerulosclerosis
N N Y N N N 81.0 1.8 1.49
10 F 73 Diabetic nephropathy N Y N Y N N 83.0 1.8 1.32
11 M 63 Nephroangiosclerosis Y N Y N N Y 95.0 2.2 1.28
12 M 73 Nephroangiosclerosis N N N N N N 72.5 1.8 1.64
13 F 63 Focal segmental
glomerulosclerosis
N N N N N N 42.5 1.4 1.69
14 M 71 Diabetic nephropathy Y Y N N N Y 79.0 1.8 1.29
15 M 82 Relapsing nephrolithiasis N Y N N N N 63.0 1.8 1.61
16 F 47 IgA nephropathy N Y N N N N 71.5 2.2 2.0
17 M 72 Nephroangiosclerosis and
bilateral a.renalis stenosis
Y N Y Y N Y 68.25 2.2 1.32
18 F 63 Relapsing pyelonephritis N N Y Y N N 57.0 1.8 1.84
19 M 67 Nephroangiosclerosis N N N N N Y 72.0 2.2 1.6
20 F 62 Nephroangiosclerosis N N Y N N Y 64.0 1.8 1.65
21 F 64 Diabetic nephropathy Y Y Y Y Y Y 51.0 1.8 2.18
Characteristics of the cohort at the beginning of the study.
M: male; F: female; Y: yes; N: no; ACE: angiotensin-converting enzyme; ARB: angiotensin receptor antagonists.976 L. Gabutti et al.
Table 2. Systemic haemodynamics
Dialysate ionized calcium concentration (mmol/l) t-test
1.25 1.5
Blood volume (%) Max. decrease 6.2 ± 4.0 6.9 ± 3.9 ns
Systolic BP (mmHg) Max. decrease 29.8 ± 11.9 23.4 ± 14.1 <0.05
Max. increase 12.0 ± 9.5 16.4 ± 12.1 <0.05
Diastolic BP (mmHg) Max. decrease 13.1 ± 4.9 11.7 ± 5.3 ns
Max. increase 8.3 ± 4.6 9.0 ± 4.7 ns
Pulse pressure (mmHg) Max. decrease 20.7 ± 11.9 19.1 ± 9.8 ns
Max. increase 12.2 ± 8.9 14.5 ± 8.3 ns
Heart rate (beat/min) Max. decrease 7.0 ± 3.3 8.0 ± 3.7 ns
Max. increase 10.3 ± 15.6 7.0 ± 10.8 ns
Stroke volume (ml) Max. decrease 19.7 ± 9.3 17.2 ± 12.9 ns
Max. increase 28.3 ± 15.7 32.1 ± 18.1 ns
Peripheral resistance (dyne s cm−5) Max. decrease 311 ± 187 341 ± 266 ns
Max. increase 950 ± 639 541 ± 331 0.05
Dialysate bicarbonate concentration (mmol/l) t-test
Low (range 26–29) High (range 32–35)
Blood volume (%) Max. decrease 7.3 ± 4.3 6.5 ± 3.3 ns
Systolic BP (mmHg) Max. decrease 25.9 ± 12.9 27.3 ± 16.1 ns
Max. increase 12.9 ± 7.1 13.9 ± 10.3 ns
Diastolic BP (mmHg) Max. decrease 12.9 ± 6.4 13.8 ± 7.2 ns
Max. increase 8.1 ± 4.2 8.7 ± 5.5 ns
Pulse pressure (mmHg) Max. decrease 20.6 ± 8.4 22.0 ± 10.0 ns
Max. increase 11.8 ± 5.5 11.3 ± 7.8 ns
Heart rate (beat/min) Max. decrease 8.2 ± 3.9 7.1 ± 3.5 0.05
Max. increase 7.3 ± 10.6 9.0 ± 14.2 ns
Stroke volume (ml) Max. decrease 18.6 ± 11.8 20.6 ± 13.6 ns
Max. increase 24.6 ± 8.8 27.3 ± 12.1 ns
Peripheral resistance (dyne s cm−5) Max. decrease 345 ± 288 286 ± 198 ns
Max. increase 520 ± 200 690 ± 455 ns
Blood volume, blood pressure (BP), heart rate, stroke volume and peripheral resistance fluctuations during dialysis using low or high dialysate calcium
and bicarbonate concentrations.
Significant differences are highlighted in bold; ns: non significant.
Kt/V was calculated using a second-generation single-
pool Daugirdas formula (Kt/V =− ln(R − 0.03) + [(4 −
3.5 × R) × (UF/W)], where R = post-dialysis BUN/
pre-dialysis BUN, UF = net ultrafiltration and W =
weight).
The free water deficit at the end of the dialysis ses-
sion was calculated on the basis of pre- and post-dialysis
serum sodium and the total body water (TBW) measured
by bioimpedance, whereas the sodium removal was esti-
mated using the following formula: (TBW × pre-dialysis
sodium) – (TBW – weight loss during dialysis) × post-
dialysis sodium.
Statistical analyses were performed using a statistical
software package (SPSS 12.0; SPSS Inc., Chicago, IL,
USA).Resultswereexpressedasmean±SD.Anevaluation
of the maximum increase and decrease in each parameter
was added to the data analysis, with the intention of ame-
liorating the understanding of the haemodynamic changes
(see Figure 2 for an explanation of the calculation method).
Comparisons between the results of the laboratory tests
(BNP,ionizedcalcium,bicarbonate,potassium,sodiumand
pH)andbetweenhaemodynamicandbioimpedanceparam-
eters were carried out with a paired t-test. Blood pressure
profiles as a function of the dialysis time were compared
using a trapezoidal estimation of the area under the curves
followed by a Wilcoxon signed-rank test. In all cases, a
P ≤ 0.05 was considered statistically significant; P was
expressed as ns (not significant), 0.05, <0.05, <0.01 and
<0.001.
The protocol of the study was approved by the local
ethical committee. All the patients gave informed consent
prior to enrolment in the study.
Results
Characteristics of the studied population
The (n = 21) characteristics of the studied population at
themomentofenrolmentwereasfollows(mean±SD):age
69.1 ± 9.9 years, weight 69.8 ± 15.5kg and male/female
ratio 0.91. The basis of haemodialyses prescriptions
were dialyzer effective surface area 1.88 ± 0.20m2; Kt/V
1.59 ± 0.26; dialysis fluid conductibility 13.8ms/cm; dial-
ysis fluid temperature 36.5◦C; effective blood flow 334 ±
69ml/min; dialysis fluid flow rate 600ml/min and dialy-
sis fluid concentration for potassium 2.64 ± 0.65mmol/l,
magnesium 0.5mml/l, acetate 3mmol/l and glucose 1g/l.Haemodynamics and dialysate bicarbonate and calcium 977
Table 3. Acid–base status, fluid balance and serum electrolytes
Dialysate ionized calcium concentration (mmol/l) t-test
1.25 1.5
BNP (ng/l) Pre-dialysis 863 ± 719 858 ± 810 Ns
ECW (l) Pre-dialysis 21.4 ± 4.5 20.8 ± 4.1 Ns
ICW (l) Pre-dialysis 16.9 ± 4.8 17.0 ± 4.8 Ns
Weight loss during dialysis (kg) 1.23 ± 0.64 1.28 ± 0.70 Ns
Ultrafiltered volume (l) 1.34 ± 0.65 1.43 ± 0.68 Ns
Free water deficit (ml) Post-dialysis −174 ± 447 0 ± 450 <0.05
Dialyses with need of staff intervention (%) 12 ± 17 10 ± 13 Ns
Sodium, whole blood (mmol/l) Pre-dialysis 134.1 ± 2.1 134.6 ± 2.5 Ns
Post-dialysis 133.3 ± 1.4 134.6 ± 1.5 <0.001
Potassium, whole blood (mmol/l) Pre-dialysis 5.49 ± 1.58 4.92 ± 0.55 Ns
Post-dialysis 3.86 ± 0.30 3.88 ± 0.26 ns
pH, whole blood Pre-dialysis 7.39 ± 0.03 7.38 ± 0.03 ns
Post-dialysis 7.48 ± 0.04 7.45 ± 0.04 <0.01
Calcium, ionized, whole blood (mmol/l) Pre-dialysis 1.13 ± 0.12 1.10 ± 0.08 Ns
Post-dialysis 1.11 ± 0.08 1.19 ± 0.05 <0.001
Dialysate bicarbonate concentration (mmol/l)
Low (range 26–29) High (range 32–35)
BNP, pre-dialysis (ng/l) Pre-dialysis 924 ± 905 754 ± 703 0.05
ECW (l) Pre-dialysis 20.9 ± 4.0 21.5 ± 4.3 0.05
ICW (l) Pre-dialysis 17.0 ± 4.8 16.8 ± 4.7 ns
Weight loss during dialysis (kg) 1.40 ± 0.83 1.36 ± 0.79 ns
Ultrafiltered volume (l) 1.67 ± 1.07 1.65 ± 1.12 ns
Free water deficit (ml) Post-dialysis −13 ± 557 −42 ± 524 ns
Sodium removal (mmol) 184.6 ± 106.8 197.7 ± 109.5 ns
Dialyses with need of staff intervention (%) 9 ± 12 10 ± 20 ns
Sodium, whole blood (mmol/l) Pre-dialysis 134.5 ± 2.4 134.5 ± 2.7 ns
Post-dialysis 134.6 ± 1.6 134.1 ± 1.6 <0.05
Potassium, whole blood (mmol/l) Pre-dialysis 5.00 ± 0.54 5.22 ± 1.63 ns
Post-dialysis 3.91 ± 0.23 3.74 ± 0.24 <0.001
pH, whole blood Pre-dialysis 7.36 ± 0.05 7.41 ± 0.09 0.05
Post-dialysis 7.44 ± 0.06 7.51 ± 0.04 <0.001
Calcium, ionized, whole blood (mmol/l) Pre-dialysis 1.14 ± 0.09 1.12 ± 0.11 ns
Post-dialysis 1.19 ± 0.08 1.14 ± 0.06 <0.01
Pre-dialysis BNP, extra- and intra-cellular body water (ECW and ICW, respectively), free water deficit at the end of dialysis,% of dialyses with need of
staff intervention, pH in whole blood and serum ionized calcium, potassium and sodium at the beginning and at the end of the dialysis sessions using
low or high dialysate calcium and bicarbonate concentrations.
Significant differences are highlighted in bold; ns: non significant.
See Table 1 for details including underlying nephropathies,
comorbidities and antihypertensive drugs in use.
Effect of bicarbonate and calcium concentrations
on systemic haemodynamics
Blood pressure, heart rate, stroke volume and peripheral
resistance fluctuations during dialysis using a low or a
high dialysate calcium or bicarbonate concentration are
shown in Tables 2 and 3. Systolic and diastolic pressures,
stroke volume and peripheral resistance as a function of
the haemodialysis time using a dialysate ionized calcium
concentration of 1.25 and 1.50mmol/l and a low or a
high bicarbonate concentration are depicted graphically in
Figures 3 and 4, respectively.
The mean difference in heart rate between the two cal-
cium and bicarbonate schedules was not significant (1.1
and 1.2 beat/min, respectively).
The results of the pulse wave analysis with calculation of
the central aortic indices using the four dialysis schedules
are shown in Table 4.
Effect on acid–base status, fluid balance and serum
electrolytes
Nodifferenceswerenoticedinthedialysateionizedsodium
concentration among the different treatment modalities
(137.8 ± 3.7, 137.2 ± 3.8, 137.4 ± 4.1 and 137.7 ± 3.8
with low and high bicarbonate and calcium concentrations,
respectively).
Using a low or a high dialysate calcium (Table 2) or
bicarbonate (Table 3) concentration, the following values
were recorded blood volume fluctuations during dialy-
sis, pre-dialysis BNP, extra-cellular, intra-cellular and to-
tal body water, free water deficit at the end of dialysis,
sodium removal, percent of dialyses with a need of staff978 L. Gabutti et al.
Table 4. Pulse wave analysis
Dialysate ionized calcium concentration (mmol/l) t-test
1.25 1.50
Operator quality index 82.7 ± 19.3 89.0 ± 8.4 ns
Systolic BP, peripheral (mmHg) 134.2 ± 18.9 144.9 ± 21.6 <0.05
Diastolic BP, peripheral (mmHg) 68.2 ± 10.8 73.9 ± 10.8 <0.05
Heart rate (beat/min) 65.1 ± 8.7 61.4 ± 9.5 <0.01
Sistolic BP, central (mmHg) 123.4 ± 19.2 133.9 ± 20.4 <0.05
Diastolic BP, central (mmHg) 68.8 ± 10.9 74.5 ± 11.2 <0.05
Ejection duration, adjusted (ms) 308.7 ± 26.1 315.3 ± 27.0 <0.05
Diastolic duration, central (ms) 631.1 ± 113.4 685.2 ± 148.7 <0.05
Augmentation index, central (%) 151.6 ± 22.9 152.7 ± 18.6 ns
Augmented pressure, central (mmHg) 18.5 ± 9.4 20.8 ± 10.0 ns
Dialysate bicarbonate concentration (mmol/l)
Low (range 26–29) High (range 32–35)
Operator quality index 87.5 ± 11.8 82.3 ± 20.8 ns
Systolic BP, peripheral (mmHg) 142.4 ± 16.8 134.0 ± 16.4 <0.05
Diastolic BP, peripheral (mmHg) 72.5 ± 10.9 67.4 ± 8.3 <0.01
Heart rate (beat/min) 60.9 ± 9.4 63.2 ± 8.8 ns
Sistolic BP, central (mmHg) 131.1 ± 16.4 123.1 ± 16.3 <0.05
Diastolic BP, central (mmHg) 73.0 ± 11.2 68.3 ± 8.5 <0.05
Ejection duration, adjusted (ms) 315.9 ± 25.0 313.1 ± 25.3 ns
Diastolic duration, central (ms) 693.1 ± 143.6 652.9 ± 125.9 ns
Augmentation index, central (%) 152.5 ± 22.9 149.6 ± 21.4 <0.05
Augmented pressure, central (mmHg) 20.0 ± 9.4 18.2 ± 8.9 ns
Results of the pulse wave analysis with calculation of the central aortic indices using a low and high dialysate calcium and bicarbonate concentrations,
respectively.
Significant differences are highlighted in bold; ns: non significant.
intervention, pH and ionized calcium, potassium and
sodium in whole blood at the beginning and at the end
of the dialysis sessions.
Discussion
Summary observations
Using three independent methods giving concordant
results (automated blood pressure monitor, finger beat-
to-beat monitor and pulse wave analyser), we demon-
strated that (i) increasing the bicarbonate concentration in
the dialysis fluid, despite a favourable effect on heart func-
tion expressed by an increased tolerance for interdialytic
volume overload, produces a slight decrease in blood pres-
sure via a reduction in peripheral resistances and (ii) in-
creasing the calcium concentration ameliorates both left
ventricular systolic and diastolic functions and, despite a
concomitant reduction in peripheral resistances, results in
an increased blood pressure and stroke volume. Contrarily
to the effect of calcium that did not persist until the follow-
ing dialysis session, some elements suggest that increasing
the bicarbonataemia generates a sustained positive effect
on cardiac function. Furthermore, a positive bicarbonate
balance could reduce arterial stiffness.
Essential results of the previous studies
In a previous study conducted with a similar design,
we demonstrated that mild metabolic alkalosis resulting
from standard bicarbonate haemodialysis (32 compared
to 26mmol/l) may induce symptomatic hypotension [22].
The haemodynamic consequences were documented mon-
itoring the lowest (−3.5mmHg) and the mean systolic
(−6.1mmHg) blood pressures along with registering the
incidence of hypotensive episodes (+3.8%) and the need
for extra isotonic saline or hypertonic glucose infusions
(+7.2%) [20]. As expected, thepH at the end of the dialysis
sessions (7.42 versus 7.48) was associated with a contrary
behaviouroftheserumionizedcalciumconcentration(1.37
versus 1.32) [22,23]. Given that alkalaemia and calcaemia
are partially dependent and are expected to be associated
with opposite cardiovascular effects [14–22] and that the
observed haemodynamic instability could have been partly
a consequence of the secondary decrease in serum ion-
ized calcium, we performed a second study with the same
design aimed at verifying whether the calcium shift sec-
ondary to alkalaemia explained the consequences of bicar-
bonate transfer on blood pressure [19]. Unfortunately, as a
consequence of an insufficient statistical power, no signif-
icant differences in blood pressures and incidence of intra-
dialytic hypotensive episodes were observed in this second
study. However, on the basis of the monitoring of the sys-
tolicbloodpressureandoftheserumionizedcalcium,itwas
possible to estimate the mean increase in the dialysate cal-
ciumconcentrationthatwouldhavebeennecessarytocoun-
terbalance the haemodynamic effect of the mild alkalaemia
induced by standard bicarbonate haemodialysis. Knowing
thatameanincreaseinserumionizedcalciumconcentration
of 0.18mmol/l was obtained with a 0.25mmol/l calciumHaemodynamics and dialysate bicarbonate and calcium 979
Fig. 3. Panels A–D: Haemodynamic consequences of changing the calcium concentration in dialysis fluids. Systolic (Panel A) and diastolic (Panel
B) pressure, stroke volume (Panel C) and peripheral resistance (Panel D) as a function of the haemodialysis time using a dialysate ionized calcium
concentration of 1.25 (black squares) and 1.50 (empty squares) mmol/l, respectively. The mean differences between the curves and the statistical
significances are superimposed in the figures.
supplementation in the dialysis fluid, a correction of the
systolicbloodpressurefallinducedbystandardbicarbonate
haemodialysis would have required an increase in dialysate
calcium concentration of ∼0.22mmol/l. Given that, in both
studies, the mean difference in serum ionized calcium con-
centration between the dialyses performed with a high or
lowbicarbonateconcentrationwasofonly0.05mmol/l(jus-
tifying a mean increase in systolic blood pressure of about
1mmHg), the haemodynamic consequences could not have
been explained by the calcium shift alone.
Effect of bicarbonate and calcium concentration
on systemic haemodynamics in the present study
We confirmed that the concentrations of both bicarbonate
and calcium in the dialysis fluid have significant reper-
cussions during haemodialysis. However, contrarily to the
first study performed with a similar design, in a group of
stable patients with a low requirement of staff intervention
duringdialysis,unfavourableconsequencesofapositivebi-
carbonate balance on the haemodialysis tolerance were not
observed. Confirming this observation, analysing the max-
imum fluctuations during dialysis of the studied haemody-
namic parameters, no differences were evident between the
dialysis performed with a low or high concentration of bi-
carbonate.Incontrast,analysingthedataofthetwocalcium
schedules, a significant difference in the maximum excur-
sions of the systolic blood pressure, with a higher increase
(16.4 versus 12.0mmHg) and alower decrease (23.4versus
29.8mmHg)usingthesupraphysiologiccalciumconcentra-
tion, was observed (see Table 2).
As expected, an increase in systolic and diastolic blood
pressures was observed using either a high calcium (+5.6
and +2.5mmHg, respectively) or a low bicarbonate (+4.7
and +1.7mmHg, respectively) concentration. The in-
creased calcium concentration was associated primarily
with changes in stroke volume (+12.3ml) and the low
bicarbonate with changes in peripheral resistances (+171
dyne s cm−5) (see Figures 2–4). Despite the resultant slight
reduction in blood pressure, the increased tolerance for
the interdialytic volume overload documented by the pre-
dialysis BNP (the significance of this finding is under-
lined by an analogous weight gain and a discordant extra-
cellular water expansion between groups; see Tables 2
and 3) suggests a favourable effect of the positive bicar-
bonate balance on cardiac function.
Returningtothehaemodynamiceffectofahighdialysate
calcium concentration, as expected, a positive effect on left
ventricular diastolic function was also documented via an
increaseintheejectionduration(+6.6ms)usingpulsewave
analysis.
With the same method, in patients treated with a high
bicarbonate concentration in the dialysis fluid, a significant980 L. Gabutti et al.
Fig. 4. Panels A–D: haemodynamic consequences of changing the bicarbonate concentration in dialysis fluids. Systolic (Panel A) and diastolic (Panel
B) pressure, stroke volume (Panel C) and peripheral resistance (Panel D) as a function of the haemodialysis time using a high (empty diamonds)
and a low (black diamonds) bicarbonate concentration in the dialysis fluid, respectively. The mean differences between the curves and the statistical
significances are superimposed in the figures.
reduction in the central augmentation index in favour of
a same behaviour of the arterial stiffness was noticed (see
Table 4). Whether or not the decrease in arterial stiffness
was fully dependent on the blood pressure reduction cannot
be stated in the present study.
Effect on acid–base status, fluid balance and serum
electrolytes
The effects of the changes in the dialysate composition
on acid–base status, ionized calcium and serum potassium
confirmed the results of the two previous studies [19–22]
(see Tables 2 and 3). As expected, the difference in the pH
at the end of the dialysis sessions (7.44 versus 7.51) was
associated with a contrary behaviour of the whole blood
ionized calcium concentration (1.19 versus 1.14mmol/l).
The lower pre-dialysis pH using a dialysate bicarbonate
in the low range (7.36 versus 7.41) suggests a less effi-
cient acidosis correction. Concerning the significant and
measurable sequestration of potassium into the intracellu-
larspace(serumpotassiumattheendofthedialysissession
with the low and high bicarbonate concentration 3.91 ver-
sus 3.74mmol/l, respectively), the independent impact on
systemic haemodynamic of the potassium kinetic during
dialysis, demonstrated in a previous study [24], was not
investigated.
Surprisingly, an unexplained, less pronounced deficit
in free water at the end of dialysis was observed; this
suggests a transient water shift towards the intracellular
space using the higher calcium concentration (see Tables 2
and 3).
Finally, the significant lower post-dialysis whole blood
sodium concentration (134.1 versus 134.6mmol/l) and the
trendtowardsbothalowerdialysateionizedsodiumconcen-
tration(137.2versus137.8mmol/l)andamorepronounced
sodium removal (197.7 versus 184.6mmol) noticed using
a dialysate bicarbonate in the high range (32 to 35mmol/l)
maybeexplainedbytheeffectofbicarbonateinthedialysis
fluids on its total-to-ionized sodium ratio. In fact, adding
6mmol/l of bicarbonate in a dialysate with a total sodium
concentration of 140mmol/l results for physical/chemical
reasons in a reduction of ∼0.5mmol/l in its ionized sodiumHaemodynamics and dialysate bicarbonate and calcium 981
concentration [25]. In the present study, it cannot be stated
to what extent the cited consequences on sodium removal
during dialysis could have contributed to the haemody-
namic changes of using a dialysate bicarbonate in the high
range.
The discrepancy between, on the one hand, the pre- and
post-dialysis plasma water ionized sodium concentration
(134.4 ± 2.4 and 134.2 ± 1.5mmol/l at the beginning and
at the end of the dialysis sessions, respectively; see Table 3)
and, on the other hand, the dialysate ionized sodium con-
centration (137.5 ± 4.1mmol/l) has been referred to the
different laboratory methods used: indirect ionometry for
the dialysate and point of care direct ionometry on whole
blood for the plasma.
In conclusion, both high bicarbonate and calcium con-
centrationsinthedialysateimprovethehaemodynamicpat-
tern during dialysis. Bicarbonate reduces arterial stiffness
and ameliorates the heart tolerance for volume overload in
the interdialytic phase, whereas calcium directly increases
stroke volume. The slight hypotensive effect of alkalaemia
should motivate a probative reduction of bicarbonate con-
centration in dialysis fluid for haemodynamic reasons, only
in the event of failure of classical tools to prevent intradia-
lytic hypotension.
The implications on systemic haemodynamics are
also to be considered when performing haemodialyses and
continuous renal replacement therapies with citrate antico-
agulation, a method that exposes patients to both metabolic
alkalosis (citrate is converted in bicarbonate) and hypocal-
caemia [26].
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